Read + Share
Waldum H. Risk of gastric and oesophageal adenocarcinomas following discontinuation of
long-term proton-pump inhibitor therapy. J Gastroenterol 2022 Dec 17. doi: 10.1007/s00535-022-01943.
PMID: 36527497
|
 |
|
Waldum H. Risk of gastric and oesophageal adenocarcinomas following discontinuation of
long-term proton-pump inhibitor therapy. J Gastroenterol 2022 Dec 17. doi: 10.1007/s00535-022-01943.
PMID: 36527497
|
|
|
|